102 related articles for article (PubMed ID: 8497718)
41. [Clinical study on aztreonam in pediatrics].
Niino M; Kida K; Matsuda H; Murase M
Jpn J Antibiot; 1985 Nov; 38(11):3334-42. PubMed ID: 4094066
[TBL] [Abstract][Full Text] [Related]
42. Clinical studies of aztreonam in Japan.
Hara K; Kobayashi H; Nishiura T; Yura J; Saito A
Rev Infect Dis; 1985; 7 Suppl 4():S810-24. PubMed ID: 3909341
[TBL] [Abstract][Full Text] [Related]
43. [Aztreonam in the treatment of nosocomial urinary infections].
Nardini A; Taddei P; Rossi F
G Ital Chemioter; 1986; 33(2-3):139-42. PubMed ID: 3678719
[No Abstract] [Full Text] [Related]
44. Effectiveness and tolerability of aztreonam in urinary tract infection caused by multiresistant bacteria.
Muzzonigro G; Minardi D; Caraceni E; Villanova A; Polito M
Acta Urol Belg; 1987; 55(3):485-90. PubMed ID: 3661329
[No Abstract] [Full Text] [Related]
45. [Aztreonam: monocenter microbiological study with prevention experience in surgery].
Malcangi A; Pesce S; Vitale M; Martinetto P
G Batteriol Virol Immunol; 1987; 80(1-12):237-51. PubMed ID: 3509031
[TBL] [Abstract][Full Text] [Related]
46. Aztreonam monotherapy as prophylaxis in transurethral resection of the prostate: a multicenter study.
Rocca Rossetti S; Boccafoschi C; Pellegrini A; Campo B; Rigatti P; Bono A; Ventriglia L
Rev Infect Dis; 1991; 13 Suppl 7():S626-8. PubMed ID: 2068471
[TBL] [Abstract][Full Text] [Related]
47. Carumonam and cefotiam in the treatment of complicated urinary tract infection (UTI): a randomized study.
Westenfelder M; Frankenschmidt A; Pelz K
Chemioterapia; 1987 Jun; 6(2 Suppl):515-6. PubMed ID: 3334612
[No Abstract] [Full Text] [Related]
48. [Prophylaxis in prostatic surgery with aztreonam. Our experience].
Moyano Calvo JL; Arellano Gañán R; Sempere Gutiérrez A; Sanz Sacristán J; Teba del Pino F; Melón Rey FJ; Herrero Torres L; Pereira Sanz I
Arch Esp Urol; 1992; 45(6):519-21. PubMed ID: 1510489
[TBL] [Abstract][Full Text] [Related]
49. Clinical experience with aztreonam in urinary and respiratory tract infections.
Hollingsworth JA; Donohoe JF; Hone R; Keelan PJ
Curr Med Res Opin; 1984; 9(5):316-22. PubMed ID: 6397335
[TBL] [Abstract][Full Text] [Related]
50. Comparative study of Ro 17-2301 (AMA-1080) and amikacin in complicated urinary tract infections.
Hahn LB; Iribarren M; Barclay C; Casellas J; Traballi C; Farinati A
Chemioterapia; 1987 Jun; 6(2 Suppl):519-21. PubMed ID: 3334614
[No Abstract] [Full Text] [Related]
51. [Clinical evaluation of aztreonam (AZT) in the treatment of complicated urinary tract infections].
Mizutani S; Iwao N; Miyoshi S; Kameoka H; Yano H; Kishimoto T; Sakurai T; Wakatsuki A; Nakamura T; Honda M
Hinyokika Kiyo; 1989 Dec; 35(12):2155-61. PubMed ID: 2694836
[TBL] [Abstract][Full Text] [Related]
52. Aztreonam.
Clark P
Obstet Gynecol Clin North Am; 1992 Sep; 19(3):519-28. PubMed ID: 1436929
[TBL] [Abstract][Full Text] [Related]
53. Comparison of aztreonam against other antibiotics used in urinary tract infections.
Khan MT; Shah SH
J Ayub Med Coll Abbottabad; 2001; 13(4):22-4. PubMed ID: 11873424
[TBL] [Abstract][Full Text] [Related]
54. [Therapeutic effects and tolerance of aztreonam in infections of the urinary tract in childhood].
Zappulla F; Mazzanti L; Sandri S; Varoli O; Bernardi F; Villa MP
G Ital Chemioter; 1985; 32(2):433-6. PubMed ID: 3833585
[No Abstract] [Full Text] [Related]
55. A single dose of aztreonam in the prevention of urinary tract infections in elderly catheterized patients.
Romanelli G; Giustina A; Cravarezza P; Bossoni S; Bodini C; Girelli A; Turano A
J Chemother; 1990 Jun; 2(3):178-81. PubMed ID: 2199628
[TBL] [Abstract][Full Text] [Related]
56. Azthreonam in the treatment of urinary tract infection: evaluation of efficacy, renal effects and nephrotoxicity.
Donadio C; Tramonti G; Garcea G; Lorusso P; Lucchetti A; Giordani R; Pierotti R; Falcone G; Bianchi C
Drugs Exp Clin Res; 1987; 13(3):167-70. PubMed ID: 3622245
[TBL] [Abstract][Full Text] [Related]
57. [Clinical evaluation of the combination of carumonam and fosfomycin in the treatment of complicated urinary tract infection].
Kakizaki H; Ishii N; Murakami S; Suzuki K; Takamizawa A; Hirano J; Mitobe K; Saito M; Hirano K; Imamura A
Hinyokika Kiyo; 1990 Jun; 36(6):731-5. PubMed ID: 2239570
[TBL] [Abstract][Full Text] [Related]
58. An update on the management of urinary tract infections in the era of antimicrobial resistance.
Bader MS; Loeb M; Brooks AA
Postgrad Med; 2017 Mar; 129(2):242-258. PubMed ID: 27712137
[TBL] [Abstract][Full Text] [Related]
59. Aztreonam: critical evaluation of the first monobactam antibiotic in treatment of urinary tract infections.
Madsen PO; Nielsen KT; Graversen PH
J Urol; 1988 Nov; 140(5):925-32. PubMed ID: 3050153
[No Abstract] [Full Text] [Related]
60. Urinary Tract Infections Among Hospitalized Adults in the Early Post-Liver Transplant Period: Prevalence, Risk Factors, Causative Agents, and Microbial Susceptibility.
Pouladfar G; Jafarpour Z; Firoozifar M; Malek Hosseini SA; Rasekh R; Khosravifard L; Janghorban P
Exp Clin Transplant; 2017 Feb; 15(Suppl 1):190-193. PubMed ID: 28260465
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
